nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxcarbazepine—Toothache—Metformin—polycystic ovary syndrome	0.0298	0.049	CcSEcCtD
Oxcarbazepine—Rigors—Metformin—polycystic ovary syndrome	0.0222	0.0365	CcSEcCtD
Oxcarbazepine—Contusion—Metformin—polycystic ovary syndrome	0.0208	0.0342	CcSEcCtD
Oxcarbazepine—Ear pain—Metformin—polycystic ovary syndrome	0.0154	0.0254	CcSEcCtD
Oxcarbazepine—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.0135	0.0222	CcSEcCtD
Oxcarbazepine—Lethargy—Metformin—polycystic ovary syndrome	0.0135	0.0221	CcSEcCtD
Oxcarbazepine—Pain in extremity—Metformin—polycystic ovary syndrome	0.0132	0.0216	CcSEcCtD
Oxcarbazepine—Migraine—Metformin—polycystic ovary syndrome	0.013	0.0213	CcSEcCtD
Oxcarbazepine—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.0122	0.02	CcSEcCtD
Oxcarbazepine—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.012	0.0198	CcSEcCtD
Oxcarbazepine—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.0118	0.0193	CcSEcCtD
Oxcarbazepine—Pancreatitis—Metformin—polycystic ovary syndrome	0.0112	0.0183	CcSEcCtD
Oxcarbazepine—Sweating increased—Metformin—polycystic ovary syndrome	0.0111	0.0182	CcSEcCtD
Oxcarbazepine—Neutropenia—Metformin—polycystic ovary syndrome	0.0107	0.0175	CcSEcCtD
Oxcarbazepine—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.0106	0.0174	CcSEcCtD
Oxcarbazepine—Infestation NOS—Metformin—polycystic ovary syndrome	0.0102	0.0167	CcSEcCtD
Oxcarbazepine—Infestation—Metformin—polycystic ovary syndrome	0.0102	0.0167	CcSEcCtD
Oxcarbazepine—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00961	0.0158	CcSEcCtD
Oxcarbazepine—Bradycardia—Metformin—polycystic ovary syndrome	0.00928	0.0152	CcSEcCtD
Oxcarbazepine—Rhinitis—Metformin—polycystic ovary syndrome	0.00914	0.015	CcSEcCtD
Oxcarbazepine—Hepatitis—Metformin—polycystic ovary syndrome	0.00912	0.015	CcSEcCtD
Oxcarbazepine—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00907	0.0149	CcSEcCtD
Oxcarbazepine—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00898	0.0147	CcSEcCtD
Oxcarbazepine—Eye disorder—Metformin—polycystic ovary syndrome	0.00852	0.014	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00846	0.0139	CcSEcCtD
Oxcarbazepine—Flushing—Metformin—polycystic ovary syndrome	0.00846	0.0139	CcSEcCtD
Oxcarbazepine—Angiopathy—Metformin—polycystic ovary syndrome	0.00827	0.0136	CcSEcCtD
Oxcarbazepine—Immune system disorder—Metformin—polycystic ovary syndrome	0.00824	0.0135	CcSEcCtD
Oxcarbazepine—Chills—Metformin—polycystic ovary syndrome	0.00818	0.0134	CcSEcCtD
Oxcarbazepine—Malnutrition—Metformin—polycystic ovary syndrome	0.00794	0.013	CcSEcCtD
Oxcarbazepine—Flatulence—Metformin—polycystic ovary syndrome	0.00782	0.0128	CcSEcCtD
Oxcarbazepine—Dysgeusia—Metformin—polycystic ovary syndrome	0.00777	0.0128	CcSEcCtD
Oxcarbazepine—Vision blurred—Metformin—polycystic ovary syndrome	0.00748	0.0123	CcSEcCtD
Oxcarbazepine—Tremor—Metformin—polycystic ovary syndrome	0.00744	0.0122	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00736	0.0121	CcSEcCtD
Oxcarbazepine—Malaise—Metformin—polycystic ovary syndrome	0.00716	0.0117	CcSEcCtD
Oxcarbazepine—Syncope—Metformin—polycystic ovary syndrome	0.00712	0.0117	CcSEcCtD
Oxcarbazepine—Palpitations—Metformin—polycystic ovary syndrome	0.00701	0.0115	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00698	0.0115	CcSEcCtD
Oxcarbazepine—Hypertension—Metformin—polycystic ovary syndrome	0.00685	0.0112	CcSEcCtD
Oxcarbazepine—Chest pain—Metformin—polycystic ovary syndrome	0.00676	0.0111	CcSEcCtD
Oxcarbazepine—Myalgia—Metformin—polycystic ovary syndrome	0.00676	0.0111	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00671	0.011	CcSEcCtD
Oxcarbazepine—Discomfort—Metformin—polycystic ovary syndrome	0.00668	0.011	CcSEcCtD
Oxcarbazepine—Modafinil—ADRA1B—polycystic ovary syndrome	0.00664	0.0768	CrCbGaD
Oxcarbazepine—Epinastine—ADRA1A—polycystic ovary syndrome	0.00649	0.0751	CrCbGaD
Oxcarbazepine—Infection—Metformin—polycystic ovary syndrome	0.00644	0.0106	CcSEcCtD
Oxcarbazepine—Shock—Metformin—polycystic ovary syndrome	0.00637	0.0105	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00635	0.0104	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00634	0.0104	CcSEcCtD
Oxcarbazepine—Skin disorder—Metformin—polycystic ovary syndrome	0.00629	0.0103	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00626	0.0103	CcSEcCtD
Oxcarbazepine—Anorexia—Metformin—polycystic ovary syndrome	0.00618	0.0101	CcSEcCtD
Oxcarbazepine—Hypotension—Metformin—polycystic ovary syndrome	0.00605	0.00994	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.0059	0.00969	CcSEcCtD
Oxcarbazepine—Nortriptyline—ADRA1D—polycystic ovary syndrome	0.00585	0.0676	CrCbGaD
Oxcarbazepine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00578	0.00948	CcSEcCtD
Oxcarbazepine—Somnolence—Metformin—polycystic ovary syndrome	0.00576	0.00945	CcSEcCtD
Oxcarbazepine—Dyspepsia—Metformin—polycystic ovary syndrome	0.0057	0.00936	CcSEcCtD
Oxcarbazepine—Decreased appetite—Metformin—polycystic ovary syndrome	0.00563	0.00924	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00559	0.00918	CcSEcCtD
Oxcarbazepine—Fatigue—Metformin—polycystic ovary syndrome	0.00559	0.00917	CcSEcCtD
Oxcarbazepine—Constipation—Metformin—polycystic ovary syndrome	0.00554	0.00909	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00534	0.00876	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.0053	0.00869	CcSEcCtD
Oxcarbazepine—Doxepin—ADRA1D—polycystic ovary syndrome	0.00525	0.0607	CrCbGaD
Oxcarbazepine—Urticaria—Metformin—polycystic ovary syndrome	0.00515	0.00845	CcSEcCtD
Oxcarbazepine—Abdominal pain—Metformin—polycystic ovary syndrome	0.00512	0.00841	CcSEcCtD
Oxcarbazepine—Nortriptyline—ADRA1B—polycystic ovary syndrome	0.00499	0.0577	CrCbGaD
Oxcarbazepine—Trimipramine—ADRA1B—polycystic ovary syndrome	0.0047	0.0543	CrCbGaD
Oxcarbazepine—Promazine—ADRA1D—polycystic ovary syndrome	0.00466	0.0539	CrCbGaD
Oxcarbazepine—Asthenia—Metformin—polycystic ovary syndrome	0.00465	0.00763	CcSEcCtD
Oxcarbazepine—Pruritus—Metformin—polycystic ovary syndrome	0.00458	0.00752	CcSEcCtD
Oxcarbazepine—Doxepin—ADRA1B—polycystic ovary syndrome	0.00448	0.0518	CrCbGaD
Oxcarbazepine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00443	0.00728	CcSEcCtD
Oxcarbazepine—Dizziness—Metformin—polycystic ovary syndrome	0.00428	0.00703	CcSEcCtD
Oxcarbazepine—Vomiting—Metformin—polycystic ovary syndrome	0.00412	0.00676	CcSEcCtD
Oxcarbazepine—Rash—Metformin—polycystic ovary syndrome	0.00408	0.0067	CcSEcCtD
Oxcarbazepine—Imipramine—ADRA1D—polycystic ovary syndrome	0.00408	0.0472	CrCbGaD
Oxcarbazepine—Dermatitis—Metformin—polycystic ovary syndrome	0.00408	0.0067	CcSEcCtD
Oxcarbazepine—Headache—Metformin—polycystic ovary syndrome	0.00406	0.00666	CcSEcCtD
Oxcarbazepine—Amitriptyline—ADRA1D—polycystic ovary syndrome	0.00406	0.0469	CrCbGaD
Oxcarbazepine—Promazine—ADRA1B—polycystic ovary syndrome	0.00398	0.046	CrCbGaD
Oxcarbazepine—Nausea—Metformin—polycystic ovary syndrome	0.00385	0.00632	CcSEcCtD
Oxcarbazepine—Imipramine—ADRA1B—polycystic ovary syndrome	0.00348	0.0403	CrCbGaD
Oxcarbazepine—Amitriptyline—ADRA1B—polycystic ovary syndrome	0.00346	0.04	CrCbGaD
Oxcarbazepine—Nortriptyline—ADRA1A—polycystic ovary syndrome	0.00336	0.0388	CrCbGaD
Oxcarbazepine—Trimipramine—ADRA1A—polycystic ovary syndrome	0.00316	0.0366	CrCbGaD
Oxcarbazepine—Promethazine—ADRA1A—polycystic ovary syndrome	0.00304	0.0352	CrCbGaD
Oxcarbazepine—Doxepin—ADRA1A—polycystic ovary syndrome	0.00301	0.0348	CrCbGaD
Oxcarbazepine—Warfarin—CYP1A1—polycystic ovary syndrome	0.00278	0.0322	CrCbGaD
Oxcarbazepine—Promazine—ADRA1A—polycystic ovary syndrome	0.00268	0.031	CrCbGaD
Oxcarbazepine—Imipramine—ADRA1A—polycystic ovary syndrome	0.00234	0.0271	CrCbGaD
Oxcarbazepine—Amitriptyline—ADRA1A—polycystic ovary syndrome	0.00233	0.0269	CrCbGaD
Oxcarbazepine—Desipramine—ADRB2—polycystic ovary syndrome	0.00164	0.019	CrCbGaD
Oxcarbazepine—ALB—Folate Metabolism—INS—polycystic ovary syndrome	0.000749	0.00246	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.000748	0.00246	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000748	0.00246	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.000748	0.00246	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00073	0.0024	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00073	0.0024	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000728	0.00239	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00072	0.00237	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.000712	0.00234	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000711	0.00234	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.000706	0.00232	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000705	0.00232	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000701	0.0023	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000701	0.0023	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—SERPINE1—polycystic ovary syndrome	0.000688	0.00226	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000676	0.00222	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00067	0.0022	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00067	0.0022	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000667	0.00219	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000662	0.00218	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000661	0.00217	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000651	0.00214	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000637	0.00209	CbGpPWpGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.00063	0.00207	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet degranulation—IGF1—polycystic ovary syndrome	0.000621	0.00204	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000602	0.00198	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000602	0.00198	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.000595	0.00196	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000592	0.00194	CbGpPWpGaD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—polycystic ovary syndrome	0.000592	0.00194	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000591	0.00194	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet degranulation—SERPINE1—polycystic ovary syndrome	0.00059	0.00194	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000588	0.00193	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000581	0.00191	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000564	0.00186	CbGpPWpGaD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—polycystic ovary syndrome	0.000562	0.00185	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000562	0.00185	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.000546	0.0018	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PDE3B—polycystic ovary syndrome	0.000546	0.00179	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000545	0.00179	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000538	0.00177	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000532	0.00175	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000523	0.00172	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000517	0.0017	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000516	0.00169	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000508	0.00167	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000504	0.00166	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000482	0.00159	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NMNAT3—polycystic ovary syndrome	0.000479	0.00158	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000478	0.00157	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000477	0.00157	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000476	0.00156	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—RACGAP1—polycystic ovary syndrome	0.000468	0.00154	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—LEP—polycystic ovary syndrome	0.000464	0.00153	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000456	0.0015	CbGpPWpGaD
Oxcarbazepine—ALB—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.000445	0.00146	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000439	0.00144	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—LPCAT2—polycystic ovary syndrome	0.000438	0.00144	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—SUOX—polycystic ovary syndrome	0.000438	0.00144	CbGpPWpGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000436	0.00143	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000432	0.00142	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000427	0.0014	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000421	0.00139	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000421	0.00138	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000416	0.00137	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NMNAT3—polycystic ovary syndrome	0.000413	0.00136	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ISYNA1—polycystic ovary syndrome	0.000408	0.00134	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—POMC—polycystic ovary syndrome	0.000406	0.00134	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet degranulation—VEGFA—polycystic ovary syndrome	0.000406	0.00133	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000405	0.00133	CbGpPWpGaD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—IL6—polycystic ovary syndrome	0.000402	0.00132	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000398	0.00131	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000397	0.00131	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—INS—polycystic ovary syndrome	0.000397	0.0013	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000394	0.00129	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000392	0.00129	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000388	0.00127	CbGpPWpGaD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—polycystic ovary syndrome	0.000386	0.00127	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000385	0.00127	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000383	0.00126	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—LPCAT2—polycystic ovary syndrome	0.000378	0.00124	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—SUOX—polycystic ovary syndrome	0.000378	0.00124	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000373	0.00123	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NMNAT3—polycystic ovary syndrome	0.000371	0.00122	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000356	0.00117	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000354	0.00116	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000351	0.00115	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ISYNA1—polycystic ovary syndrome	0.000351	0.00115	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—AKR1C2—polycystic ovary syndrome	0.000347	0.00114	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—TEAD2—polycystic ovary syndrome	0.000347	0.00114	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000346	0.00114	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000343	0.00113	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—LPCAT2—polycystic ovary syndrome	0.000339	0.00111	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—SUOX—polycystic ovary syndrome	0.000339	0.00111	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000335	0.0011	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—IL6—polycystic ovary syndrome	0.000327	0.00108	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.00032	0.00105	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ISYNA1—polycystic ovary syndrome	0.000315	0.00104	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000314	0.00103	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—POMC—polycystic ovary syndrome	0.000314	0.00103	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00031	0.00102	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000308	0.00101	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000304	0.000999	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—TEAD2—polycystic ovary syndrome	0.000299	0.000981	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—AKR1C2—polycystic ovary syndrome	0.000299	0.000981	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PNPLA2—polycystic ovary syndrome	0.00029	0.000955	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000288	0.000945	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000287	0.000943	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PLAT—polycystic ovary syndrome	0.000286	0.000939	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000283	0.000929	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	0.000275	0.000905	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—SRD5A1—polycystic ovary syndrome	0.000275	0.000905	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	0.000275	0.000905	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000273	0.000897	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	0.000268	0.000881	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	0.000268	0.000881	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000266	0.000874	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—STAR—polycystic ovary syndrome	0.000263	0.000863	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	0.000262	0.00086	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.00026	0.000854	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000258	0.000847	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000254	0.000834	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000253	0.000833	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000251	0.000824	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PNPLA2—polycystic ovary syndrome	0.00025	0.000822	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.00025	0.000821	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000247	0.000813	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—IL6—polycystic ovary syndrome	0.000243	0.000798	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—SRD5A1—polycystic ovary syndrome	0.000237	0.000779	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	0.000234	0.000769	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—STAR—polycystic ovary syndrome	0.000226	0.000744	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000226	0.000743	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	0.000225	0.000738	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000224	0.000735	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	0.000223	0.000734	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000223	0.000733	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—GNAS—polycystic ovary syndrome	0.000219	0.000721	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	0.000213	0.0007	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000204	0.00067	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000204	0.00067	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	0.000204	0.000669	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	0.000203	0.000667	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—HMMR—polycystic ovary syndrome	0.000202	0.000663	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000201	0.00066	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	0.000199	0.000654	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	0.000193	0.000634	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	0.000192	0.000632	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.00019	0.000625	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.00019	0.000624	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.00019	0.000623	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000189	0.000621	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	0.000181	0.000595	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00018	0.000592	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	0.00018	0.000591	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	0.000177	0.000583	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—LHB—polycystic ovary syndrome	0.000175	0.000577	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—IL6—polycystic ovary syndrome	0.000173	0.00057	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	0.000173	0.000568	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	0.000172	0.000565	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	0.000171	0.000563	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000171	0.000561	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	0.000166	0.000546	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	0.000166	0.000544	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000162	0.000532	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000161	0.00053	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000161	0.00053	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	0.000159	0.000523	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	0.000157	0.000518	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	0.000157	0.000517	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	0.000154	0.000506	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	0.000153	0.000502	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	0.000149	0.00049	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	0.000148	0.000488	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—RRM2—polycystic ovary syndrome	0.000148	0.000486	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	0.000146	0.00048	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—YAP1—polycystic ovary syndrome	0.000143	0.000469	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—IGF1—polycystic ovary syndrome	0.000142	0.000467	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—AKT2—polycystic ovary syndrome	0.000142	0.000466	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	0.000137	0.000451	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NAMPT—polycystic ovary syndrome	0.000137	0.00045	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000136	0.000448	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	0.000135	0.000445	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000135	0.000444	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000135	0.000443	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000134	0.000442	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	0.000133	0.000437	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	0.000128	0.000421	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000128	0.000421	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	0.000128	0.00042	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—TH—polycystic ovary syndrome	0.000126	0.000416	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	0.000126	0.000414	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	0.000123	0.000404	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	0.000123	0.000404	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000122	0.000402	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000122	0.000401	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	0.000122	0.000399	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000121	0.000397	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	0.000116	0.00038	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	0.000115	0.000377	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	0.000113	0.000371	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—TH—polycystic ovary syndrome	0.000109	0.000358	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000109	0.000358	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	0.000106	0.000348	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000104	0.000341	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	0.000103	0.000339	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	9.96e-05	0.000327	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	9.83e-05	0.000323	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—TH—polycystic ovary syndrome	9.77e-05	0.000321	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	9.51e-05	0.000313	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	9.47e-05	0.000311	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	9.32e-05	0.000306	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	9.27e-05	0.000305	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	9.26e-05	0.000304	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	8.96e-05	0.000295	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	8.94e-05	0.000294	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GNAS—polycystic ovary syndrome	8.89e-05	0.000292	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	8.69e-05	0.000286	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NCOR1—polycystic ovary syndrome	8.47e-05	0.000278	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	8.25e-05	0.000271	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	8.03e-05	0.000264	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	7.99e-05	0.000263	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	7.98e-05	0.000262	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	7.7e-05	0.000253	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	7.6e-05	0.00025	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—MTHFR—polycystic ovary syndrome	7.48e-05	0.000246	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	7.4e-05	0.000243	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	7.31e-05	0.00024	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	7.21e-05	0.000237	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	7.05e-05	0.000232	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	6.95e-05	0.000228	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—INS—polycystic ovary syndrome	6.91e-05	0.000227	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	6.9e-05	0.000227	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	6.79e-05	0.000223	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	6.72e-05	0.000221	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PPARG—polycystic ovary syndrome	6.07e-05	0.000199	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—POMC—polycystic ovary syndrome	5.99e-05	0.000197	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—INS—polycystic ovary syndrome	5.95e-05	0.000196	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	5.88e-05	0.000193	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	5.72e-05	0.000188	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	5.45e-05	0.000179	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	5.38e-05	0.000177	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	5.37e-05	0.000177	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—INS—polycystic ovary syndrome	5.34e-05	0.000176	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.8e-05	0.000158	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	4.57e-05	0.00015	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	4.33e-05	0.000142	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	4.04e-05	0.000133	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.28e-05	0.000108	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.23e-05	0.000106	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.21e-05	0.000106	CbGpPWpGaD
